Volume 11, Issue 3 pp. 332-335

Durable remission following a third allogeneic stem cell transplantation in a patient with repeatedly relapsing SAA. The importance of stroma cells for sustained engraftment?

Daniela Weber-Mzell

Daniela Weber-Mzell

Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine

Search for more papers by this author
Christian Urban

Christian Urban

Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine

Search for more papers by this author
Martin Benesch

Martin Benesch

Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine

Search for more papers by this author
Tanja Rojacher

Tanja Rojacher

Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine

Search for more papers by this author
Birgit Zois

Birgit Zois

Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine

Search for more papers by this author
Gerald Höfler

Gerald Höfler

Institute of Pathology, Medical University of Graz, Graz, Austria

Search for more papers by this author
Wolfgang Schwinger

Wolfgang Schwinger

Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine

Search for more papers by this author
First published: 31 March 2007
Citations: 5
Wolfgang Schwinger, Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Auenbruggerplatz 30, A-8036 Graz, Austria
Tel.: 0043 316 385 83329
Fax: 0043 316 385 3450
E-mail: [email protected]

Abstract

Abstract: Diagnosis of acquired AATP which finally progressed to SAA was established in an eight-yr-old boy. PBSCT from an HLA-identical unrelated donor using high numbers of CD34+ selected stem cells was performed and resulted in complete remission for almost two yr. However, SAA reoccurred with 100% donor hematopoiesis and was reversed by a second CD 34+ selected PBSCT from the same donor. Declining blood cell counts after an interval of two yr indicated second relapse. Chimerism analysis in PB and BM aspirates revealed a small autologous cell population of 4–12% and 2–11%, respectively. Finally, a third transplantation with unmanipulated BM from the same donor resulted in sustained remission with 100% donor hematopoiesis. The patient is in complete remission for more than five yr following the third SCT. Late graft failure or late graft rejection known to occur after transplantation of highly purified CD34+ cells, or even graft exhaustion caused by stromal dysfunction due to the underlying disease necessitated a third transplantation. Regardless of the cause of relapse, transplantation of unmanipulated BM instead of highly purified PBSCTs led to a permanent and stable engraftment in a third attempt after two previous PBSCTs.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.